Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
AST-001
DRUG
2 trials
Sponsors
Ascentawits Pharmaceuticals, Ltd
, Astrogen, Inc.
Conditions
Autism Spectrum Disorder
Pancreatic Cancer
Solid Tumor
Phase 1
A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors
Recruiting
NCT06245330
Ascentawits Pharmaceuticals, Ltd
Pancreatic Cancer, Solid Tumor
Start: 2022-07-07
End: 2027-08-31
Target: 180
Updated: 2024-02-07
Phase 3
A Study to Evaluate the Efficacy and Safety of AST-001 in ASD Children
Completed
NCT06333964
Astrogen, Inc.
Autism Spectrum Disorder
Start: 2023-08-29
End: 2024-12-05
Updated: 2026-02-02